Patient dies in Bristol Myers Squibb autoimmune CAR-T trial
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Patient dies in Bristol Myers Squibb autoimmune CAR-T trial" is generating significant coverage in the Business category, with 1 articles from 1 distinct sources tracked by PULSE so far.
Outlets currently covering the story include WSJ. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 13m ago.
Quick answers
Why is "Patient dies in Bristol Myers Squibb autoimmune CAR-T trial" trending?
Because 1 independent news sources published 1 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (1)
Topics
Related trends
Bristol Myers reveals death in MS CAR-T trial, has answer for safety signal in lupus trial
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Travis Kelce supports Taylor Swift in sweet behind-the-scenes look at her directing ‘Patient Zero’ music video
1 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
Patient disputed an $85,000 hospital bill, then an AI sweep added nearly $20,000 more
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down
Caribou Biosciences, a biotech firm co-founded by Nobel laureate Jennifer Doudna, is halting its pipeline and reducing staff amid potential closure.
Kenya’s First Ebola Patient Flew To Nairobi Two Days Before He Died
Kenya confirms its first-ever Ebola case and death, triggering quarantines and exposing border screening gaps.
Taylor Swift’s ‘Patient Zero’ Debuts at No. 1 on Billboard Hot 100
4 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.